Virtu Financial’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Virtu Financial’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,445	Closed	-$221K	–	2252
2023 Q3	$221K	Buy	+20,445	New	+$219K	0.02%	625
2023 Q2	–	Sell	-14,099	Closed	-$147K	–	2310
2023 Q1	$147K	Buy	14,099 +2,698	+24%	+$27.9K	0.02%	845
2022 Q4	$117K	Buy	+11,401	New	+$116K	0.02%	900

Virtu Financial's BIOS Position: Q4 2023 in Review

Virtu Financial sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 20,445 shares — an estimated $221K sold.

Virtu Financial first reported a position in BIOS in Q4 2022 and held it in 3 quarters. The position peaked at $221K in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Virtu Financial reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Virtu Financial sold 20,445 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $221K.
Virtu Financial first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q4 2022 and held it in 3 quarters.
Virtu Financial's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $221K in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Virtu Financial's 13F filing for Q4 2023, filed 26 Feb 2024.